ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Cellect Biotechnology Ltd.
13.17
0.0000
成交量:
- -
成交额:
- -
市值:
1,291.23万
市盈率:
-2.56
高:
13.17
开:
13.17
低:
13.17
收:
13.17
52周最高:
35.52
52周最低:
6.88
股本:
98.04万
流通股本:
94.29万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-5.1505
每股收益(LYR):
-6.1107
净资产收益率:
-120.42%
总资产收益率:
-47.79%
市净率:
8.34
市盈率(LYR):
-2.16
数据加载中...
总览
公司
新闻资讯
公告
2021/03/29
年度报告
20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16
超过5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13
超过5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/04
[修订]年度报告
20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/22
超过5%披露
[Amend] General statement of acquisition of beneficial ownership
2020/04/03
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/03
年度报告
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/02
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14
超过5%披露
[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/17
超过5%披露
Statement of acquisition of beneficial ownership by individuals
2020/01/10
超过5%披露
Statement of acquisition of beneficial ownership by individuals
2020/01/10
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/07
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03
超过5%披露
[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/30
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/APOP/filings"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APOP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APOP\",,,,,undefined,":{"symbol":"APOP","market":"US","secType":"STK","nameCN":"Cellect Biotechnology Ltd.","latestPrice":13.17,"timestamp":1636142400000,"preClose":13.17,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":942862,"shares":980434,"eps":-5.150534,"marketStatus":"交易中","change":0,"latestTime":"02-26 13:01:32 EST","open":13.17,"high":13.17,"low":13.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.150534,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772139600000},"marketStatusCode":2,"adr":0,"adrRate":400,"listingDate":523425600000,"exchange":"NASDAQ","adjPreClose":13.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APOP\",,,,,undefined,":{"symbol":"APOP","floatShares":942862,"roa":"-47.79%","roe":"-120.42%","lyrEps":-6.110709,"shares":980434,"dividePrice":0,"high":13.17,"amplitude":0,"preClose":13.17,"low":13.17,"week52Low":6.88,"pbRate":"8.34","week52High":35.52,"institutionHeld":0,"latestPrice":13.17,"eps":-5.150534,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.150534,"open":13.17,"prevYearClose":8.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APOP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-09-24","symbol":"APOP","defaultRemindTime":1632490200000,"type":"split","dateTimestamp":1632456000000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2021-08-24","symbol":"APOP","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629777600000,"reportTimeType":"","actualEps":-0.43},{"market":"US","date":"2021-03-29","symbol":"APOP","fiscalQuarterEnding":"2020/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1616990400000,"reportTimeType":"","actualEps":-0.39},{"market":"US","date":"2020-11-20","symbol":"APOP","fiscalQuarterEnding":"2020/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1605848400000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2020-08-12","symbol":"APOP","fiscalQuarterEnding":"2020/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1597204800000,"reportTimeType":"","actualEps":-0.69}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APOP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APOP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APOP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APOP","date":"2021-10-29","current":-2.557016,"percent":0.578313,"low":-18.175493,"twenty":-6.410673,"median":-2.868349,"eighty":-1.428707,"high":-0.746847,"avg":-3.979545,"sd":2.737054,"marketCap":12912315},"quantilePoints":[{"date":"2021-02-26","current":-2.336953,"twenty":-7.06617,"median":-3.92791,"eighty":-1.344969,"marketCap":13448645},{"date":"2021-03-05","current":-1.913999,"twenty":-7.057229,"median":-3.88573,"eighty":-1.34803,"marketCap":10946572},{"date":"2021-03-12","current":-2.289908,"twenty":-7.039707,"median":-3.860295,"eighty":-1.351357,"marketCap":13135886},{"date":"2021-03-19","current":-2.403165,"twenty":-7.027611,"median":-3.804582,"eighty":-1.355689,"marketCap":13878689},{"date":"2021-03-26","current":-3.25897,"twenty":-7.020893,"median":-3.722331,"eighty":-1.359012,"marketCap":18648267},{"date":"2021-04-01","current":-2.260874,"twenty":-7.019392,"median":-3.612174,"eighty":-1.359242,"marketCap":12275798},{"date":"2021-04-09","current":-2.17048,"twenty":-7.018274,"median":-3.58467,"eighty":-1.36216,"marketCap":11923944},{"date":"2021-04-16","current":-1.787263,"twenty":-7.01609,"median":-3.565172,"eighty":-1.373538,"marketCap":9851914},{"date":"2021-04-23","current":-1.654651,"twenty":-7.009871,"median":-3.538081,"eighty":-1.375145,"marketCap":9187301},{"date":"2021-04-30","current":-1.804107,"twenty":-7.007382,"median":-3.526353,"eighty":-1.376341,"marketCap":10047389},{"date":"2021-05-07","current":-1.707825,"twenty":-7.006331,"median":-3.520323,"eighty":-1.378959,"marketCap":9500060},{"date":"2021-05-14","current":-1.821226,"twenty":-6.997555,"median":-3.489178,"eighty":-1.389417,"marketCap":10047389},{"date":"2021-05-21","current":-1.894162,"twenty":-6.974944,"median":-3.475128,"eighty":-1.397221,"marketCap":10516528},{"date":"2021-05-28","current":-2.080504,"twenty":-6.968423,"median":-3.448518,"eighty":-1.405324,"marketCap":11572090},{"date":"2021-06-04","current":-2.305849,"twenty":-6.967002,"median":-3.435334,"eighty":-1.412364,"marketCap":12823127},{"date":"2021-06-11","current":-2.225111,"twenty":-6.944447,"median":-3.411608,"eighty":-1.414381,"marketCap":12353988},{"date":"2021-06-18","current":-2.943759,"twenty":-6.943672,"median":-3.369853,"eighty":-1.420261,"marketCap":16224383},{"date":"2021-06-25","current":-2.553941,"twenty":-6.936173,"median":-3.357588,"eighty":-1.422483,"marketCap":14191448},{"date":"2021-07-02","current":-2.576013,"twenty":-6.931081,"median":-3.337765,"eighty":-1.423118,"marketCap":14230543},{"date":"2021-07-09","current":-2.42572,"twenty":-6.922511,"median":-3.265876,"eighty":-1.423753,"marketCap":13370455},{"date":"2021-07-16","current":-2.931924,"twenty":-6.917015,"median":-3.220969,"eighty":-1.425846,"marketCap":16107098},{"date":"2021-07-23","current":-3.163014,"twenty":-6.909757,"median":-3.175683,"eighty":-1.428011,"marketCap":17475420},{"date":"2021-07-30","current":-3.066532,"twenty":-6.90228,"median":-3.109984,"eighty":-1.431172,"marketCap":17162661},{"date":"2021-08-06","current":-2.880984,"twenty":-6.875578,"median":-2.988079,"eighty":-1.431172,"marketCap":16146193},{"date":"2021-08-13","current":-2.774348,"twenty":-6.839235,"median":-2.926661,"eighty":-1.431172,"marketCap":15598865},{"date":"2021-08-20","current":-2.82369,"twenty":-6.822282,"median":-2.904234,"eighty":-1.431172,"marketCap":15755244},{"date":"2021-08-27","current":-3.141131,"twenty":-6.766824,"median":-2.898002,"eighty":-1.428707,"marketCap":16146193},{"date":"2021-09-03","current":-4.170685,"twenty":-6.72392,"median":-2.898002,"eighty":-1.428707,"marketCap":21569553},{"date":"2021-09-10","current":-4.813592,"twenty":-6.649428,"median":-2.898002,"eighty":-1.428707,"marketCap":24903023},{"date":"2021-09-17","current":-4.812316,"twenty":-6.601998,"median":-2.898002,"eighty":-1.428707,"marketCap":24863806},{"date":"2021-09-24","current":-18.175493,"twenty":-6.571346,"median":-2.898002,"eighty":-1.428707,"marketCap":94121664},{"date":"2021-10-01","current":-3.515209,"twenty":-6.543481,"median":-2.898002,"eighty":-1.428707,"marketCap":18098811},{"date":"2021-10-08","current":-3.440507,"twenty":-6.516789,"median":-2.898002,"eighty":-1.428707,"marketCap":17638007},{"date":"2021-10-15","current":-3.10517,"twenty":-6.468163,"median":-2.898002,"eighty":-1.428707,"marketCap":15971269},{"date":"2021-10-22","current":-2.740991,"twenty":-6.443977,"median":-2.881372,"eighty":-1.428707,"marketCap":14157466},{"date":"2021-10-29","current":-2.463442,"twenty":-6.410673,"median":-2.868349,"eighty":-1.428707,"marketCap":12912315}],"updateTime":1772128892982},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"APOP\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"12912334","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021018137-APOP","pdf_url":null,"pub_time":1616947200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"APOP","title":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/0001213900-21-018137-index.htm","us_notice_code":"Form 20-F","us_title_en":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f20f2020_cellectbiotech.htm","type":"20-F","id":"NTFILEGYCNzvPZLAaxQSNB","market":"us","size":1836629},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex2-5_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex2-5_cellectbio.htm","type":"EX-2.5","id":"NTFILEAWba5wT7nLafzfb7","market":"us","size":123551},{"description":"SUBSIDIARIES OF CELLECT BIOTECHNOLOGY LTD","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex8-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex8-1_cellectbio.htm","type":"EX-8.1","id":"NTFILE2KLRXMyXbfAJyBBA","market":"us","size":2345},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex12-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex12-1_cellectbio.htm","type":"EX-12.1","id":"NTFILE2ogwhgqvUdfz224L","market":"us","size":10645},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex12-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex12-2_cellectbio.htm","type":"EX-12.2","id":"NTFILEHoD9MNxkTW1QApeU","market":"us","size":10610},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex13-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex13-1_cellectbio.htm","type":"EX-13.1","id":"NTFILE7u45xcFzFcXVCkdi","market":"us","size":3021},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex13-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex13-2_cellectbio.htm","type":"EX-13.2","id":"NTFILE2iQwRa1mggRANjEh","market":"us","size":3103},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex15-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex15-1_cellectbio.htm","type":"EX-15.1","id":"NTFILEG7MeLjGAHEKJVjzv","market":"us","size":2087},{"description":"CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex15-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex15-2_cellectbio.htm","type":"EX-15.2","id":"NTFILE2Pot5qsrsgNNsVGF","market":"us","size":3375},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex16-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex16-1_cellectbio.htm","type":"EX-16.1","id":"NTFILEDqmoh2J2k63PX8rk","market":"us","size":1839},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE4KPVL4oBDrscWU7C","market":"us","size":76684},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE5t8V6vzTMWYWfdcA","market":"us","size":10853},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/img_003.jpg","primary":false,"translateUrl":null,"linkName":"img_003.jpg","type":"GRAPHIC","id":"NTFILEFA6knBrZVycZMWua","market":"us","size":6959},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/ex15-2_001.jpg","primary":false,"translateUrl":null,"linkName":"ex15-2_001.jpg","type":"GRAPHIC","id":"NTFILE6TPJYn693SG5DxCG","market":"us","size":3995},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/ex15-2_002.jpg","primary":false,"translateUrl":null,"linkName":"ex15-2_002.jpg","type":"GRAPHIC","id":"NTFILEFXMhJGVd26kuFEFY","market":"us","size":7848}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2021-03-29 00:00","pubTimestamp":1616947200,"title_zh":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12912322","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921023190-APOP","pdf_url":null,"pub_time":1613404800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465921023190/0001104659-21-023190-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1649553/000110465921023190/tm216476d3_sc13ga.htm","primary":true,"translateUrl":null,"linkName":"tm216476d3_sc13ga.htm","type":"SC 13G/A","id":"NTFILEHh1nA38G6fWUk2vw","market":"us","size":71539}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-02-16 00:00","pubTimestamp":1613404800,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12912323","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266421000169-APOP","pdf_url":null,"pub_time":1610467200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000090266421000169/0000902664-21-000169-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY LTD.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1469336/000090266421000169/p21-0081sc13g.htm","primary":true,"translateUrl":null,"linkName":"p21-0081sc13g.htm","type":"SC 13G","id":"NTFILEZNYyaZuHRMeCfMKM","market":"us","size":74417}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-01-13 00:00","pubTimestamp":1610467200,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10221303","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020020139-APOP","pdf_url":null,"pub_time":1596470400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"APOP","title":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"[修订]年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/0001213900-20-020139-index.htm","us_notice_code":"Form 20-F/A","us_title_en":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 20-F","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/f20f2019a1_cellectbio.htm","primary":true,"translateUrl":null,"linkName":"f20f2019a1_cellectbio.htm","type":"20-F/A","id":"NTFILEEa6Q6R5GqbGcKesh","market":"us","size":50185},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE5B7yDX33knwG6Tud","market":"us","size":10493},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILEHEazHGJ8UwwhMxvn","market":"us","size":10149}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[修订]年度报告","pubTime":"2020-08-04 00:00","pubTimestamp":1596470400,"title_zh":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9571575","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020009811-APOP","pdf_url":null,"pub_time":1587484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] General statement of acquisition of beneficial ownership","symbol":"APOP","title":"[Amend] General statement of acquisition of beneficial ownership","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020009811/0001213900-20-009811-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 2 TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020009811/ea120945-13da2yarkoni_cellec.htm","primary":true,"translateUrl":null,"linkName":"ea120945-13da2yarkoni_cellec.htm","type":"SC 13D/A","id":"NTFILE41GuPKL5kwqZvsYk","market":"us","size":37120}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-04-22 00:00","pubTimestamp":1587484800,"title_zh":"Amend] General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9413044","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008495-APOP","pdf_url":null,"pub_time":1585843200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/0001213900-20-008495-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/ea120287ex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"ea120287ex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE7itBBYH9d6A9Qpc3","market":"us","size":154033},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/ea120287-6k_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"ea120287-6k_cellectbiotech.htm","type":"6-K","id":"NTFILEHVkkugZgnAn4VUux","market":"us","size":14225},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEGNtHfio5eqBWTZSS","market":"us","size":1927}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-04-03 00:00","pubTimestamp":1585843200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9412972","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008493-APOP","pdf_url":null,"pub_time":1585843200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"APOP","title":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/0001213900-20-008493-index.htm","us_notice_code":"Form 20-F","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f20f2019_cellectbiotech.htm","type":"20-F","id":"NTFILEC6jAz15UzjhV2dsL","market":"us","size":2539465},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex2-5_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex2-5_cellectbio.htm","type":"EX-2.5","id":"NTFILEGgmnkKFfhq4i5njf","market":"us","size":122435},{"description":"SUBSIDIARIES OF CELLECT BIOTECHNOLOGY LTD.","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex8-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex8-1_cellectbio.htm","type":"EX-8.1","id":"NTFILE9Vx4XepptyAD5JZt","market":"us","size":2304},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex12-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex12-1_cellectbio.htm","type":"EX-12.1","id":"NTFILE8PfvpVSqBrWsqRdo","market":"us","size":10559},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex12-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex12-2_cellectbio.htm","type":"EX-12.2","id":"NTFILEFGMFcWF5E7opwN63","market":"us","size":10593},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex13-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex13-1_cellectbio.htm","type":"EX-13.1","id":"NTFILEAZG47tF3p3avpi2x","market":"us","size":3023},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex13-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex13-2_cellectbio.htm","type":"EX-13.2","id":"NTFILEDLsPbjAtrLrGRqs5","market":"us","size":3027},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex15-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex15-1_cellectbio.htm","type":"EX-15.1","id":"NTFILEFqZXr1feo7qqwmod","market":"us","size":3166},{"description":"CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex15-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex15-2_cellectbio.htm","type":"EX-15.2","id":"NTFILE3cBjYVcGpFbuxVPW","market":"us","size":3113},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex16-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex16-1_cellectbio.htm","type":"EX-16.1","id":"NTFILE4XGCUAU5Jm5TK2X4","market":"us","size":2970},{"description":"XBRL INSTANCE FILE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231.xml","type":"EX-101.INS","id":"NTFILE136B6CU6XTMNUxFS","market":"us","size":1415161},{"description":"XBRL SCHEMA FILE","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231.xsd","primary":false,"translateUrl":null,"linkName":"apop-20191231.xsd","type":"EX-101.SCH","id":"NTFILE6mS4wC2Wgmgti7pu","market":"us","size":87463},{"description":"XBRL CALCULATION FILE","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_cal.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_cal.xml","type":"EX-101.CAL","id":"NTFILE3mi6XKGPymcytwZg","market":"us","size":29843},{"description":"XBRL DEFINITION FILE","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_def.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_def.xml","type":"EX-101.DEF","id":"NTFILER8PsoRiRDgnLfCvE","market":"us","size":234432},{"description":"XBRL LABEL FILE","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_lab.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_lab.xml","type":"EX-101.LAB","id":"NTFILEGPtbpWAvkbvY4vDZ","market":"us","size":478670},{"description":"XBRL PRESENTATION FILE","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_pre.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_pre.xml","type":"EX-101.PRE","id":"NTFILE3WDL6fjsfUkiwdyJ","market":"us","size":239693},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE7o36eGVvKqpBSPZ8","market":"us","size":75616},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE71zuUdUL5twMWER3","market":"us","size":79756},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/fin_001.jpg","primary":false,"translateUrl":null,"linkName":"fin_001.jpg","type":"GRAPHIC","id":"NTFILE7RccLZxsVYZFmjch","market":"us","size":10655},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/ex15-2.jpg","primary":false,"translateUrl":null,"linkName":"ex15-2.jpg","type":"GRAPHIC","id":"NTFILE4gmkxjSwE3FxjRNF","market":"us","size":3995}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2020-04-03 00:00","pubTimestamp":1585843200,"title_zh":"Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9407007","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008412-APOP","pdf_url":null,"pub_time":1585756800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008412/0001213900-20-008412-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY RECEIVES NEW PATENT ALLOWANCE IN CHINA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008412/ea120314ex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"ea120314ex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE9dYfz8nWnNyAeZMn","market":"us","size":9748},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008412/ea120314-6k_cellect.htm","primary":false,"translateUrl":null,"linkName":"ea120314-6k_cellect.htm","type":"6-K","id":"NTFILE45sbzajcX9hqfWcH","market":"us","size":13227}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-04-02 00:00","pubTimestamp":1585756800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9158861","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020005359-APOP","pdf_url":null,"pub_time":1583251200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/0001213900-20-005359-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY AND CANNDOC LTD. TO ENTER INTO STRATEGI PHARMA GRADE CANNA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ea119242ex99-1_cellectbio.htm","primary":true,"translateUrl":null,"linkName":"ea119242ex99-1_cellectbio.htm","type":"EX-99.1","id":"NTFILE2BT9JBLx8Ckqggso","market":"us","size":21115},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ea119242-6k_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"ea119242-6k_cellectbiotech.htm","type":"6-K","id":"NTFILE5A1VDXRVRxAK8Fe3","market":"us","size":12670},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE95PHDdsdkZcHZ9jd","market":"us","size":6439},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILE6Gw6w2PBbe2kqBLH","market":"us","size":11258},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEEYzTFcDkenSvFPZA","market":"us","size":4982}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-03-04 00:00","pubTimestamp":1583251200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9099349","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312520038322-APOP","pdf_url":null,"pub_time":1581609600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"[Amend] Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000119312520038322/0001193125-20-038322-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"[Amend] Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1491072/000119312520038322/d891716dsc13ga.htm","primary":true,"translateUrl":null,"linkName":"d891716dsc13ga.htm","type":"SC 13G/A","id":"NTFILEDjGiXjBrrL5auyq8","market":"us","size":119288}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-02-14 00:00","pubTimestamp":1581609600,"title_zh":"Amend] Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9027658","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020001905-APOP","pdf_url":null,"pub_time":1580054400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/0001213900-20-001905-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k012720_cellectbiotech.htm","type":"6-K","id":"NTFILEGrkmrW1sMbZ7b1db","market":"us","size":14715},{"description":"NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S SPECIAL GENERAL MEETING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720ex99-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f6k012720ex99-1_cellectbio.htm","type":"EX-99.1","id":"NTFILEAoddsJx9QbHvSQkC","market":"us","size":42322},{"description":"PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S SPECIAL","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720ex99-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f6k012720ex99-2_cellectbio.htm","type":"EX-99.2","id":"NTFILE2jW7ZSZSXQnyeLVA","market":"us","size":13968},{"description":"VOTING INSTRUCTION CARD FOR HOLDERS OF THE COMPANYS ADS HOLDERS WITH RESPECT TO","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720ex99-3_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f6k012720ex99-3_cellectbio.htm","type":"EX-99.3","id":"NTFILE5NsHez1zJQTUD6N1","market":"us","size":1425},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE4b9zfGnYEAyJRcHH","market":"us","size":5257},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/ex99-2_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILEJDfbppA9zgTpdN4d","market":"us","size":5289},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/proxy_001.jpg","primary":false,"translateUrl":null,"linkName":"proxy_001.jpg","type":"GRAPHIC","id":"NTFILE8uBVqs5uc8fthPEk","market":"us","size":64038},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/proxy_002.jpg","primary":false,"translateUrl":null,"linkName":"proxy_002.jpg","type":"GRAPHIC","id":"NTFILEEXQAcae47EKeGNjG","market":"us","size":70159}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-27 00:00","pubTimestamp":1580054400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9004353","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465920004930-APOP","pdf_url":null,"pub_time":1579190400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465920004930/0001104659-20-004930-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1649553/000110465920004930/a20-3412_1sc13g.htm","primary":true,"translateUrl":null,"linkName":"a20-3412_1sc13g.htm","type":"SC 13G","id":"NTFILE5ayNJNSXCJ2hUyPd","market":"us","size":102698}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-01-17 00:00","pubTimestamp":1579190400,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8984124","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266420000160-APOP","pdf_url":null,"pub_time":1578585600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000090266420000160/0000902664-20-000160-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY LTD.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1469336/000090266420000160/p20-0099sc13g.htm","primary":true,"translateUrl":null,"linkName":"p20-0099sc13g.htm","type":"SC 13G","id":"NTFILEDK78unNt9UkrJe1i","market":"us","size":80411}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-01-10 00:00","pubTimestamp":1578585600,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8983708","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000726-APOP","pdf_url":null,"pub_time":1578585600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000726/0001213900-20-000726-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 6-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000726/f6k010920c_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k010920c_cellectbiotech.htm","type":"6-K","id":"NTFILEFuULvjypTNATojLm","market":"us","size":7406}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-10 00:00","pubTimestamp":1578585600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8983705","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000724-APOP","pdf_url":null,"pub_time":1578585600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/0001213900-20-000724-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820b_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k010820b_cellectbiotech.htm","type":"6-K","id":"NTFILEB2qw3JvwMMqAnCYF","market":"us","size":26867},{"description":"OPINION OF DORON TIKOTZKY KANTOR GUTMAN & AMIT GROSS","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820bex5-1_cellect.htm","primary":false,"translateUrl":null,"linkName":"f6k010820bex5-1_cellect.htm","type":"EX-5.1","id":"NTFILE8dpmSAFcVxpRPg3A","market":"us","size":25374},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820bex10-1_cellect.htm","primary":false,"translateUrl":null,"linkName":"f6k010820bex10-1_cellect.htm","type":"EX-10.1","id":"NTFILE9Gm19djoFJcvaMSu","market":"us","size":187880},{"description":"PLACEMENT AGENT AGREEMENT DATED JANUARY 7, 2020","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820bex10-2_cellect.htm","primary":false,"translateUrl":null,"linkName":"f6k010820bex10-2_cellect.htm","type":"EX-10.2","id":"NTFILE6khNHJGNdcQRFqiW","market":"us","size":55074},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEAyCcGcfQUQ9FCqyE","market":"us","size":19328}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-10 00:00","pubTimestamp":1578585600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8976902","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000459-APOP","pdf_url":null,"pub_time":1578412800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000459/0001213900-20-000459-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JANUARY 8, 2020","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000459/f6k010820ex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"f6k010820ex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE8fKTQbWTUggDotQS","market":"us","size":11739},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000459/f6k010820_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"f6k010820_cellectbiotech.htm","type":"6-K","id":"NTFILEGcsfBJRN9JqxAq63","market":"us","size":10949}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-08 00:00","pubTimestamp":1578412800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8972619","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000322-APOP","pdf_url":null,"pub_time":1578326400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/0001213900-20-000322-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JANUARY 7, 2020","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/f6k010720bex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"f6k010720bex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE3HM3hSk5jXssJd1c","market":"us","size":17150},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/f6k010720b_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"f6k010720b_cellectbiotech.htm","type":"6-K","id":"NTFILE4EdhzrfxzWiiAKVg","market":"us","size":16041},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEHpoQTBMUECuvfU4r","market":"us","size":4141}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-07 00:00","pubTimestamp":1578326400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8968539","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000253-APOP","pdf_url":null,"pub_time":1578240000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000253/0001213900-20-000253-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000253/f6k010620a_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k010620a_cellectbiotech.htm","type":"6-K","id":"NTFILECQgKxBEoyPXEMHm9","market":"us","size":12349}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-06 00:00","pubTimestamp":1578240000,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8960888","market":"us","labels":[],"media":"sec.gov","original_id":"AN153561020000009-APOP","pdf_url":null,"pub_time":1577980800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"[Amend] Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000153561020000009/0001535610-20-000009-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"[Amend] Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SABBY 13G-A APOP 1.03.20","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1535610/000153561020000009/apop0120.txt","primary":true,"translateUrl":null,"linkName":"apop0120.txt","type":"SC 13G/A","id":"NTFILEG6SbRZa7Z8qjX7g2","market":"us","size":13473}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-01-03 00:00","pubTimestamp":1577980800,"title_zh":"Amend] Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8924572","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019027135-APOP","pdf_url":null,"pub_time":1577635200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390019027135/0001213900-19-027135-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390019027135/f6k123019_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k123019_cellectbiotech.htm","type":"6-K","id":"NTFILE6sgK8A2EpYJwzLZs","market":"us","size":10333}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-12-30 00:00","pubTimestamp":1577635200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":163,"code":"91000000","status":"200"}]}}